On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the FDA Emergency Use Authorization granted to P23 Labs.

The P23 Labs’ TaqPath SARS-CoV-2 assay, combined with OMNIgene-ORAL (OM-505), facilitates the detection of nucleic acid from SARS-CoV-2 using oral fluid samples self-collected at-home with telemedicine support or in an assisted living setting, at a doctorﾒs office or at a drive through collection site.